Please login to the form below

Not currently logged in

Ferring Pharmaceuticals promotes Aaron Graff

He takes up role as chief commercial officer and joins its executive board

Aaron GraffSwiss biopharmaceutical company Ferring Pharmaceuticals has promoted Aaron Graff to chief commercial officer and executive vice president.

He was previously CEO of Ferring’s US operations and in his new role he will also sit on the Saint-Prex-based firm’s executive board.

Graff first joined Ferring in 2002 as VP of global marketing, business development and medical affairs, based in Copenhagen.

After leading the acquisition and integration of Israeli biopharmaceutical company BTG in 2005, he relocated his team to the newly established Ferring International Center in Saint-Prex.

He was then made senior VP, Asia region and global marketing, and since 2010 has led Ferring’s stateside operations from its US headquarters in New Jersey, first as chief operating officer and since 2016 as CEO.

Michel Pettigrew, president of Ferring Pharmaceuticals’ executive board and chief operating officer, said: “Under Aaron’s leadership in the United States, our US business grew at double-digit rates. His broad, global professional experience and track record make him uniquely qualified for this important role.”

Prior to joining Ferring, Graff worked at Bristol-Myers Squibb for over 17 years in a variety of sales, marketing and commercial operations management positions.

2nd June 2017

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...
The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...